- Home
- HOWL vs KPLT Comparison
HOWL vs KPLT Comparison
Compare HOWL & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- KPLT
- Stock Information
- Founded
- HOWL 2017
- KPLT 2012
- Country
- HOWL United States
- KPLT United States
- Employees
- HOWL N/A
- KPLT N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- KPLT Diversified Commercial Services
- Sector
- HOWL Health Care
- KPLT Consumer Discretionary
- Exchange
- HOWL Nasdaq
- KPLT Nasdaq
- Market Cap
- HOWL 64.5M
- KPLT 52.2M
- IPO Year
- HOWL 2021
- KPLT N/A
- Fundamental
- Price
- HOWL $1.56
- KPLT $11.13
- Analyst Decision
- HOWL Strong Buy
- KPLT Hold
- Analyst Count
- HOWL 5
- KPLT 1
- Target Price
- HOWL $7.20
- KPLT $10.00
- AVG Volume (30 Days)
- HOWL 1.3M
- KPLT 76.3K
- Earning Date
- HOWL 11-14-2025
- KPLT 11-12-2025
- Dividend Yield
- HOWL N/A
- KPLT N/A
- EPS Growth
- HOWL N/A
- KPLT N/A
- EPS
- HOWL N/A
- KPLT N/A
- Revenue
- HOWL N/A
- KPLT $267,101,999.00
- Revenue This Year
- HOWL N/A
- KPLT $22.88
- Revenue Next Year
- HOWL N/A
- KPLT $10.98
- P/E Ratio
- HOWL N/A
- KPLT N/A
- Revenue Growth
- HOWL N/A
- KPLT 13.04
- 52 Week Low
- HOWL $0.60
- KPLT $5.08
- 52 Week High
- HOWL $2.96
- KPLT $24.34
- Technical
- Relative Strength Index (RSI)
- HOWL 45.71
- KPLT 37.38
- Support Level
- HOWL $1.55
- KPLT $11.91
- Resistance Level
- HOWL $1.83
- KPLT $12.94
- Average True Range (ATR)
- HOWL 0.13
- KPLT 1.07
- MACD
- HOWL -0.03
- KPLT 0.05
- Stochastic Oscillator
- HOWL 14.71
- KPLT 4.08
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.